http://www.jcog.jp/document/9407.htm WebIn Japan, two Phase 2 trials (JCOG8807 and JCOG9407) demon-strated the efficacy of CF in patients with advanced ESCC, resulting in a response rate of 33.3–35.9%, median OS of 201.5 days and 1-

食道癌 JCOG 9905-DI 臨床試験サマリ OncoTribune

WebSold: 2 beds, 1 bath, 944 sq. ft. condo located at 2094 Legacy Ridge Vw #207, Colorado Springs, CO 80910 sold for $236,000 on Mar 7, 2024. MLS# 9107700. Welcome Home! … Web27 mar 2008 · MIC (mitomycin 6 mg/m (2), ifosfamide 3 g/m (2), and cisplatin 50 mg/m (2)) was given in day 1 as an outpatient regimen and repeated every 3 weeks. All 32 enrolled patients were male with median age of 57 years. Prior esophagectomy had been performed in 21 patients (65.6%) and 11 patients (34.4%) were metastatic disease at initial diagnosis. gotcha hand game image

National Center for Biotechnology Information

Web1 apr 2024 · No standard adjuvant treatment has been established for patients with curatively resected biliary tract cancer. S-1 has been reported to show promising efficacy with mild toxicity profiles in patients with advanced biliary tract cancer, and adjuvant S-1 therapy has been demonstrated to provide survival benefit in patients with resected … http://www.jcog.jp/document/9407.htm Web食道癌の治療にシスプラチンが導入されてから、いくつかのレジメンが利用可能となった。シスプラチン併用の化学療法では15.0-76.2%の奏効割合が報告されており、導入以前 … gotcha hacks